Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tautu, Petre
1985.
Methodical Problems in Early Detection Programmes.
Vol. 26,
Issue. ,
p.
10.
Mehata, K. M.
and
Deivamoney Selvam, D.
1986.
A class of general stochastic compartmental systems.
Bulletin of Mathematical Biology,
Vol. 48,
Issue. 5-6,
p.
509.
Skates, Steven J
Pauler, Donna K
and
Jacobs, Ian J
2001.
Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers.
Journal of the American Statistical Association,
Vol. 96,
Issue. 454,
p.
429.
2007.
Bayesian Biostatistics and Diagnostic Medicine.
p.
165.
Wu, Dongfeng
Rosner, Gary L.
and
Broemeling, Lyle D.
2007.
Bayesian Inference for the Lead Time in Periodic Cancer Screening.
Biometrics,
Vol. 63,
Issue. 3,
p.
873.
Wu, Dongfeng
Erwin, Diane
and
Rosner, Gary L.
2009.
A projection of benefits due to fecal occult blood test for colorectal cancer.
Cancer Epidemiology,
Vol. 33,
Issue. 3-4,
p.
212.
Wu, Dongfeng
and
Rosner, Gary L.
2010.
Frontiers in Computational and Systems Biology.
Vol. 15,
Issue. ,
p.
203.
Shows, Justin
and
Wu, Dongfeng
2011.
Inferences for the Lead Time in Breast Cancer Screening Trials under a Stable Disease Model.
Cancers,
Vol. 3,
Issue. 2,
p.
2131.
Jang, Hyejeong
Kim, Seongho
and
Wu, Dongfeng
2013.
Bayesian lead time estimation for the Johns Hopkins Lung Project data.
Journal of Epidemiology and Global Health,
Vol. 3,
Issue. 3,
p.
157.
Ge, Zhiyun
Heitjan, Daniel F.
Gerber, David E.
Xuan, Lei
and
Pruitt, Sandi L.
2018.
Estimating lead‐time bias in lung cancer diagnosis of patients with previous cancers.
Statistics in Medicine,
Vol. 37,
Issue. 16,
p.
2516.
Liu, Ruiqi
Pérez, Adriana
and
Wu, Dongfeng
2018.
Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.
Journal of Healthcare Informatics Research,
Vol. 2,
Issue. 4,
p.
353.
Rice, John D.
Johnson, Brent A.
and
Strawderman, Robert L.
2022.
Screening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherence.
Lifetime Data Analysis,
Vol. 28,
Issue. 4,
p.
605.
Zhu, Kehao
Zhao, Ying-Qi
and
Zheng, Yingye
2024.
Designing cancer screening trials for reduction in late-stage cancer incidence.
Biometrics,
Vol. 80,
Issue. 3,